Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

CatalYm today announced the appointment of Scott Clarke as Chief Executive Officer. Mr. Clarke brings over two decades of ...

Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced an ag ...

Abstract: Recently, in the technical magazines, articles have appeared advocating the use of a 277/480-volt 3-phase 4-wire grounded neutral distribution system for manufacturing plants. In these ...

The structure of electrical systems relies on a straightforward setup. Electricity is distributed using two wires—a phase wire and a neutral wire—which deliver the electrical energy to residential ...

Two people are dead after a crash in an embankment on Interstate 435 near 103rd Street. Kansas City police said that the ...

Pittsburgh Regional Transit is welcoming community members to weigh in on the second phase of its University Line Bus Rapid ...

Clinical Trial Application for global Phase 3 trials with nizubaglustat in GM1/GM2 gangliosidoses and Niemann-Pick Disease ...

“The suzetrigine Phase 2 results clearly show reduced pain intensity from baseline in the active drug arm, and the potential for suzetrigine to fill an unmet need in relieving LSR pain, a ...

A regional non-profit is helping kick off fundraising for an expansive renovation effort of the Westfair fairgrounds.

Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease - Veligrotug met all primary and secondary ...